Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Altimmune, Inc.PIP · Entity 5349 | VP, CFO, Treasurer, Secretary | December 21, 2016 | December 22, 2016 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Altimmune, Inc.
Report date December 21, 2016 · Filed December 22, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.0001 per shareSEC Table I · non-derivative | Direct | 126,346 |
Ending reported balance
After 2016-12-21 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2016-12-21 · Exercise / conversion · Acquired 5,000 · Balance 108,689 Row 2 · 2016-12-21 · Exercise / conversion · Acquired 17,657 · Balance 126,346 |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.71 · Expires 2024-12-08 | Direct | 5,000 |
Reported balance
After 2016-12-21 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2016-12-21 · Exercise / conversion · Disposed 5,000 · Balance 5,000 F1: These options became exercisable in 4 equal annual installments, with the first installment exercisable on December 8, 2014. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.66 · Expires 2025-12-03 | Direct | 35,312 |
Reported balance
After 2016-12-21 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2016-12-21 · Exercise / conversion · Disposed 17,657 · Balance 35,312 F2: These options were granted on December 3, 2015, and vest over a 3 year period with 25% vesting on the grant date and an additional 25% vesting on each of the first, second and third anniversaries of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: These options became exercisable in 4 equal annual installments, with the first installment exercisable on December 8, 2014.
F2: These options were granted on December 3, 2015, and vest over a 3 year period with 25% vesting on the grant date and an additional 25% vesting on each of the first, second and third anniversaries of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 21, 2016 Filed Dec 22, 2016 21:15 UTC | Altimmune, Inc. PIP · Entity 5349 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 17,657 | $0.00 Strike: $1.66 | $0.00 |
DisclosureSEC source: 0001144204-16-140974 · v455595_4.xml · derivative · entry 4 MACNEILL PHILIP · CIK 0001529856 · VP, CFO, Treasurer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,312 Underlying: Common Stock · 17,657 shares Expires 2025-12-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on December 3, 2015, and vest over a 3 year period with 25% vesting on the grant date and an additional 25% vesting on each of the first, second and third anniversaries of the grant date. Read SEC document |
| December 21, 2016 Filed Dec 22, 2016 21:15 UTC | Altimmune, Inc. PIP · Entity 5349 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $1.71 | $0.00 |
DisclosureSEC source: 0001144204-16-140974 · v455595_4.xml · derivative · entry 3 MACNEILL PHILIP · CIK 0001529856 · VP, CFO, Treasurer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2024-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options became exercisable in 4 equal annual installments, with the first installment exercisable on December 8, 2014. Read SEC document |
| December 21, 2016 Filed Dec 22, 2016 21:15 UTC | Altimmune, Inc. PIP · Entity 5349 | Exercise / conversionCommon Stock, par value $0.0001 per share | 17,657 | $1.66 | $29,310.62 |
DisclosureSEC source: 0001144204-16-140974 · v455595_4.xml · nonDerivative · entry 2 MACNEILL PHILIP · CIK 0001529856 · VP, CFO, Treasurer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,346 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 21, 2016 Filed Dec 22, 2016 21:15 UTC | Altimmune, Inc. PIP · Entity 5349 | Exercise / conversionCommon Stock, par value $0.0001 per share | 5,000 | $1.71 | $8,550.00 |
DisclosureSEC source: 0001144204-16-140974 · v455595_4.xml · nonDerivative · entry 1 MACNEILL PHILIP · CIK 0001529856 · VP, CFO, Treasurer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 20, 2016 Filed Sep 21, 2016 21:09 UTC | Altimmune, Inc. PIP · Entity 5349 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 17,656 | $0.00 Strike: $1.66 | $0.00 |
DisclosureSEC source: 0001144204-16-124773 · v449203_4.xml · derivative · entry 12 MACNEILL PHILIP · CIK 0001529856 · VP, CFO, Treasurer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,969 Underlying: Common Stock · 17,656 shares Expires 2025-12-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on December 3, 2015, and vest over a 3 year period with 25% vesting on the grant date and an additional 25% vesting on each of the first, second and third anniversaries of the grant date. Read SEC document |
| September 20, 2016 Filed Sep 21, 2016 21:09 UTC | Altimmune, Inc. PIP · Entity 5349 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $1.71 | $0.00 |
DisclosureSEC source: 0001144204-16-124773 · v449203_4.xml · derivative · entry 11 MACNEILL PHILIP · CIK 0001529856 · VP, CFO, Treasurer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2024-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options became exercisable in 4 equal annual installments, with the first installment exercisable on December 8, 2014. Read SEC document |
| September 20, 2016 Filed Sep 21, 2016 21:09 UTC | Altimmune, Inc. PIP · Entity 5349 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 14,063 | $0.00 Strike: $1.94 | $0.00 |
DisclosureSEC source: 0001144204-16-124773 · v449203_4.xml · derivative · entry 10 MACNEILL PHILIP · CIK 0001529856 · VP, CFO, Treasurer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,687 Underlying: Common Stock · 14,063 shares Expires 2024-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options became exercisable in 4 equal annual installments, with the first installment exercisable on January 29, 2014. Read SEC document |
| September 20, 2016 Filed Sep 21, 2016 21:09 UTC | Altimmune, Inc. PIP · Entity 5349 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,625 | $0.00 Strike: $1.13 | $0.00 |
DisclosureSEC source: 0001144204-16-124773 · v449203_4.xml · derivative · entry 9 MACNEILL PHILIP · CIK 0001529856 · VP, CFO, Treasurer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,625 shares Expires 2022-12-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options became exercisable in 4 equal annual installments, with the first installment exercisable on December 3, 2012. Read SEC document |
| September 20, 2016 Filed Sep 21, 2016 21:09 UTC | Altimmune, Inc. PIP · Entity 5349 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,845 | $0.00 Strike: $1.21 | $0.00 |
DisclosureSEC source: 0001144204-16-124773 · v449203_4.xml · derivative · entry 8 MACNEILL PHILIP · CIK 0001529856 · VP, CFO, Treasurer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,845 shares Expires 2021-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 20, 2016 Filed Sep 21, 2016 21:09 UTC | Altimmune, Inc. PIP · Entity 5349 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,500 | $0.00 Strike: $1.21 | $0.00 |
DisclosureSEC source: 0001144204-16-124773 · v449203_4.xml · derivative · entry 7 MACNEILL PHILIP · CIK 0001529856 · VP, CFO, Treasurer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,500 shares Expires 2021-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options became exercisable in 4 equal annual installments, with the first installment exercisable on December 1, 2011. Read SEC document |
| September 20, 2016 Filed Sep 21, 2016 21:09 UTC | Altimmune, Inc. PIP · Entity 5349 | Exercise / conversionCommon Stock, par value $0.0001 per share | 17,656 | $1.66 | $29,308.96 |
DisclosureSEC source: 0001144204-16-124773 · v449203_4.xml · nonDerivative · entry 6 MACNEILL PHILIP · CIK 0001529856 · VP, CFO, Treasurer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 20, 2016 Filed Sep 21, 2016 21:09 UTC | Altimmune, Inc. PIP · Entity 5349 | Exercise / conversionCommon Stock, par value $0.0001 per share | 10,000 | $1.71 | $17,100.00 |
DisclosureSEC source: 0001144204-16-124773 · v449203_4.xml · nonDerivative · entry 5 MACNEILL PHILIP · CIK 0001529856 · VP, CFO, Treasurer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,033 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 20, 2016 Filed Sep 21, 2016 21:09 UTC | Altimmune, Inc. PIP · Entity 5349 | Exercise / conversionCommon Stock, par value $0.0001 per share | 14,063 | $1.94 | $27,282.22 |
DisclosureSEC source: 0001144204-16-124773 · v449203_4.xml · nonDerivative · entry 4 MACNEILL PHILIP · CIK 0001529856 · VP, CFO, Treasurer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,033 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 20, 2016 Filed Sep 21, 2016 21:09 UTC | Altimmune, Inc. PIP · Entity 5349 | Exercise / conversionCommon Stock, par value $0.0001 per share | 5,625 | $1.13 | $6,356.25 |
DisclosureSEC source: 0001144204-16-124773 · v449203_4.xml · nonDerivative · entry 3 MACNEILL PHILIP · CIK 0001529856 · VP, CFO, Treasurer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,970 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 20, 2016 Filed Sep 21, 2016 21:09 UTC | Altimmune, Inc. PIP · Entity 5349 | Exercise / conversionCommon Stock, par value $0.0001 per share | 1,845 | $1.21 | $2,232.45 |
DisclosureSEC source: 0001144204-16-124773 · v449203_4.xml · nonDerivative · entry 2 MACNEILL PHILIP · CIK 0001529856 · VP, CFO, Treasurer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,345 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 20, 2016 Filed Sep 21, 2016 21:09 UTC | Altimmune, Inc. PIP · Entity 5349 | Exercise / conversionCommon Stock, par value $0.0001 per share | 4,500 | $1.21 | $5,445.00 |
DisclosureSEC source: 0001144204-16-124773 · v449203_4.xml · nonDerivative · entry 1 MACNEILL PHILIP · CIK 0001529856 · VP, CFO, Treasurer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.